Pharma & Healthcare
Global Goserelin Drug Market Insights, Forecast to 2030
- Mar 11, 25
- ID: 4208
- Pages: 73
- Figures: 105
- Views: 4
Goserelin is a medication which is used to suppress production of the sex hormones (testosterone and estrogen), particularly in the treatment of breast and prostate cancer. It is an injectable gonadotropin releasing hormone agonist (GnRH agonist).
The global Goserelin Drug market is projected to grow from US$ 1259 million in 2024 to US$ 1734 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Goserelin Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Goserelin Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Goserelin Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Goserelin Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Goserelin Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Goserelin Drug sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Segment by Type
3.6 mg
10.8 mg
Segment by Application
Prostate Cancer
Breast Cancer
Endometriosis
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Goserelin Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Goserelin Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Goserelin Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
The global Goserelin Drug market is projected to grow from US$ 1259 million in 2024 to US$ 1734 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Goserelin Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Goserelin Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Goserelin Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Goserelin Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Goserelin Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Goserelin Drug sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Segment by Type
3.6 mg
10.8 mg
Segment by Application
Prostate Cancer
Breast Cancer
Endometriosis
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Goserelin Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Goserelin Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Goserelin Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Goserelin Drug Product Introduction
1.2 Market by Type
1.2.1 Global Goserelin Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 3.6 mg
1.2.3 10.8 mg
1.3 Market by Application
1.3.1 Global Goserelin Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Prostate Cancer
1.3.3 Breast Cancer
1.3.4 Endometriosis
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Goserelin Drug Sales Estimates and Forecasts 2019-2030
2.2 Global Goserelin Drug Revenue by Region
2.2.1 Global Goserelin Drug Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Goserelin Drug Revenue by Region (2019-2024)
2.2.3 Global Goserelin Drug Revenue by Region (2025-2030)
2.2.4 Global Goserelin Drug Revenue Market Share by Region (2019-2030)
2.3 Global Goserelin Drug Sales Estimates and Forecasts 2019-2030
2.4 Global Goserelin Drug Sales by Region
2.4.1 Global Goserelin Drug Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Goserelin Drug Sales by Region (2019-2024)
2.4.3 Global Goserelin Drug Sales by Region (2025-2030)
2.4.4 Global Goserelin Drug Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Goserelin Drug Sales by Manufacturers
3.1.1 Global Goserelin Drug Sales by Manufacturers (2019-2024)
3.1.2 Global Goserelin Drug Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Goserelin Drug in 2023
3.2 Global Goserelin Drug Revenue by Manufacturers
3.2.1 Global Goserelin Drug Revenue by Manufacturers (2019-2024)
3.2.2 Global Goserelin Drug Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Goserelin Drug Revenue in 2023
3.3 Global Key Players of Goserelin Drug, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Goserelin Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Goserelin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Goserelin Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Goserelin Drug, Product Offered and Application
3.8 Global Key Manufacturers of Goserelin Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Goserelin Drug Sales by Type
4.1.1 Global Goserelin Drug Historical Sales by Type (2019-2024)
4.1.2 Global Goserelin Drug Forecasted Sales by Type (2025-2030)
4.1.3 Global Goserelin Drug Sales Market Share by Type (2019-2030)
4.2 Global Goserelin Drug Revenue by Type
4.2.1 Global Goserelin Drug Historical Revenue by Type (2019-2024)
4.2.2 Global Goserelin Drug Forecasted Revenue by Type (2025-2030)
4.2.3 Global Goserelin Drug Revenue Market Share by Type (2019-2030)
4.3 Global Goserelin Drug Price by Type
4.3.1 Global Goserelin Drug Price by Type (2019-2024)
4.3.2 Global Goserelin Drug Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Goserelin Drug Sales by Application
5.1.1 Global Goserelin Drug Historical Sales by Application (2019-2024)
5.1.2 Global Goserelin Drug Forecasted Sales by Application (2025-2030)
5.1.3 Global Goserelin Drug Sales Market Share by Application (2019-2030)
5.2 Global Goserelin Drug Revenue by Application
5.2.1 Global Goserelin Drug Historical Revenue by Application (2019-2024)
5.2.2 Global Goserelin Drug Forecasted Revenue by Application (2025-2030)
5.2.3 Global Goserelin Drug Revenue Market Share by Application (2019-2030)
5.3 Global Goserelin Drug Price by Application
5.3.1 Global Goserelin Drug Price by Application (2019-2024)
5.3.2 Global Goserelin Drug Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Goserelin Drug Market Size by Type
6.1.1 US & Canada Goserelin Drug Sales by Type (2019-2030)
6.1.2 US & Canada Goserelin Drug Revenue by Type (2019-2030)
6.2 US & Canada Goserelin Drug Market Size by Application
6.2.1 US & Canada Goserelin Drug Sales by Application (2019-2030)
6.2.2 US & Canada Goserelin Drug Revenue by Application (2019-2030)
6.3 US & Canada Goserelin Drug Market Size by Country
6.3.1 US & Canada Goserelin Drug Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Goserelin Drug Sales by Country (2019-2030)
6.3.3 US & Canada Goserelin Drug Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Goserelin Drug Market Size by Type
7.1.1 Europe Goserelin Drug Sales by Type (2019-2030)
7.1.2 Europe Goserelin Drug Revenue by Type (2019-2030)
7.2 Europe Goserelin Drug Market Size by Application
7.2.1 Europe Goserelin Drug Sales by Application (2019-2030)
7.2.2 Europe Goserelin Drug Revenue by Application (2019-2030)
7.3 Europe Goserelin Drug Market Size by Country
7.3.1 Europe Goserelin Drug Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Goserelin Drug Sales by Country (2019-2030)
7.3.3 Europe Goserelin Drug Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Goserelin Drug Market Size
8.1.1 China Goserelin Drug Sales (2019-2030)
8.1.2 China Goserelin Drug Revenue (2019-2030)
8.2 China Goserelin Drug Market Size by Application
8.2.1 China Goserelin Drug Sales by Application (2019-2030)
8.2.2 China Goserelin Drug Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Goserelin Drug Market Size by Type
9.1.1 Asia Goserelin Drug Sales by Type (2019-2030)
9.1.2 Asia Goserelin Drug Revenue by Type (2019-2030)
9.2 Asia Goserelin Drug Market Size by Application
9.2.1 Asia Goserelin Drug Sales by Application (2019-2030)
9.2.2 Asia Goserelin Drug Revenue by Application (2019-2030)
9.3 Asia Goserelin Drug Sales by Region
9.3.1 Asia Goserelin Drug Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Goserelin Drug Revenue by Region (2019-2030)
9.3.3 Asia Goserelin Drug Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Goserelin Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Goserelin Drug Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Goserelin Drug Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Goserelin Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Goserelin Drug Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Goserelin Drug Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Goserelin Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Goserelin Drug Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Goserelin Drug Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Goserelin Drug Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Goserelin Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 AstraZeneca Goserelin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 TerSera
11.2.1 TerSera Company Information
11.2.2 TerSera Overview
11.2.3 TerSera Goserelin Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 TerSera Goserelin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 TerSera Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Goserelin Drug Industry Chain Analysis
12.2 Goserelin Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Goserelin Drug Production Mode & Process
12.4 Goserelin Drug Sales and Marketing
12.4.1 Goserelin Drug Sales Channels
12.4.2 Goserelin Drug Distributors
12.5 Goserelin Drug Customers
13 Market Dynamics
13.1 Goserelin Drug Industry Trends
13.2 Goserelin Drug Market Drivers
13.3 Goserelin Drug Market Challenges
13.4 Goserelin Drug Market Restraints
14 Key Findings in The Global Goserelin Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Goserelin Drug Product Introduction
1.2 Market by Type
1.2.1 Global Goserelin Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 3.6 mg
1.2.3 10.8 mg
1.3 Market by Application
1.3.1 Global Goserelin Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Prostate Cancer
1.3.3 Breast Cancer
1.3.4 Endometriosis
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Goserelin Drug Sales Estimates and Forecasts 2019-2030
2.2 Global Goserelin Drug Revenue by Region
2.2.1 Global Goserelin Drug Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Goserelin Drug Revenue by Region (2019-2024)
2.2.3 Global Goserelin Drug Revenue by Region (2025-2030)
2.2.4 Global Goserelin Drug Revenue Market Share by Region (2019-2030)
2.3 Global Goserelin Drug Sales Estimates and Forecasts 2019-2030
2.4 Global Goserelin Drug Sales by Region
2.4.1 Global Goserelin Drug Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Goserelin Drug Sales by Region (2019-2024)
2.4.3 Global Goserelin Drug Sales by Region (2025-2030)
2.4.4 Global Goserelin Drug Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Goserelin Drug Sales by Manufacturers
3.1.1 Global Goserelin Drug Sales by Manufacturers (2019-2024)
3.1.2 Global Goserelin Drug Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Goserelin Drug in 2023
3.2 Global Goserelin Drug Revenue by Manufacturers
3.2.1 Global Goserelin Drug Revenue by Manufacturers (2019-2024)
3.2.2 Global Goserelin Drug Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Goserelin Drug Revenue in 2023
3.3 Global Key Players of Goserelin Drug, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Goserelin Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Goserelin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Goserelin Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Goserelin Drug, Product Offered and Application
3.8 Global Key Manufacturers of Goserelin Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Goserelin Drug Sales by Type
4.1.1 Global Goserelin Drug Historical Sales by Type (2019-2024)
4.1.2 Global Goserelin Drug Forecasted Sales by Type (2025-2030)
4.1.3 Global Goserelin Drug Sales Market Share by Type (2019-2030)
4.2 Global Goserelin Drug Revenue by Type
4.2.1 Global Goserelin Drug Historical Revenue by Type (2019-2024)
4.2.2 Global Goserelin Drug Forecasted Revenue by Type (2025-2030)
4.2.3 Global Goserelin Drug Revenue Market Share by Type (2019-2030)
4.3 Global Goserelin Drug Price by Type
4.3.1 Global Goserelin Drug Price by Type (2019-2024)
4.3.2 Global Goserelin Drug Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Goserelin Drug Sales by Application
5.1.1 Global Goserelin Drug Historical Sales by Application (2019-2024)
5.1.2 Global Goserelin Drug Forecasted Sales by Application (2025-2030)
5.1.3 Global Goserelin Drug Sales Market Share by Application (2019-2030)
5.2 Global Goserelin Drug Revenue by Application
5.2.1 Global Goserelin Drug Historical Revenue by Application (2019-2024)
5.2.2 Global Goserelin Drug Forecasted Revenue by Application (2025-2030)
5.2.3 Global Goserelin Drug Revenue Market Share by Application (2019-2030)
5.3 Global Goserelin Drug Price by Application
5.3.1 Global Goserelin Drug Price by Application (2019-2024)
5.3.2 Global Goserelin Drug Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Goserelin Drug Market Size by Type
6.1.1 US & Canada Goserelin Drug Sales by Type (2019-2030)
6.1.2 US & Canada Goserelin Drug Revenue by Type (2019-2030)
6.2 US & Canada Goserelin Drug Market Size by Application
6.2.1 US & Canada Goserelin Drug Sales by Application (2019-2030)
6.2.2 US & Canada Goserelin Drug Revenue by Application (2019-2030)
6.3 US & Canada Goserelin Drug Market Size by Country
6.3.1 US & Canada Goserelin Drug Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Goserelin Drug Sales by Country (2019-2030)
6.3.3 US & Canada Goserelin Drug Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Goserelin Drug Market Size by Type
7.1.1 Europe Goserelin Drug Sales by Type (2019-2030)
7.1.2 Europe Goserelin Drug Revenue by Type (2019-2030)
7.2 Europe Goserelin Drug Market Size by Application
7.2.1 Europe Goserelin Drug Sales by Application (2019-2030)
7.2.2 Europe Goserelin Drug Revenue by Application (2019-2030)
7.3 Europe Goserelin Drug Market Size by Country
7.3.1 Europe Goserelin Drug Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Goserelin Drug Sales by Country (2019-2030)
7.3.3 Europe Goserelin Drug Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Goserelin Drug Market Size
8.1.1 China Goserelin Drug Sales (2019-2030)
8.1.2 China Goserelin Drug Revenue (2019-2030)
8.2 China Goserelin Drug Market Size by Application
8.2.1 China Goserelin Drug Sales by Application (2019-2030)
8.2.2 China Goserelin Drug Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Goserelin Drug Market Size by Type
9.1.1 Asia Goserelin Drug Sales by Type (2019-2030)
9.1.2 Asia Goserelin Drug Revenue by Type (2019-2030)
9.2 Asia Goserelin Drug Market Size by Application
9.2.1 Asia Goserelin Drug Sales by Application (2019-2030)
9.2.2 Asia Goserelin Drug Revenue by Application (2019-2030)
9.3 Asia Goserelin Drug Sales by Region
9.3.1 Asia Goserelin Drug Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Goserelin Drug Revenue by Region (2019-2030)
9.3.3 Asia Goserelin Drug Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Goserelin Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Goserelin Drug Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Goserelin Drug Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Goserelin Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Goserelin Drug Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Goserelin Drug Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Goserelin Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Goserelin Drug Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Goserelin Drug Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Goserelin Drug Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Goserelin Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 AstraZeneca Goserelin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 TerSera
11.2.1 TerSera Company Information
11.2.2 TerSera Overview
11.2.3 TerSera Goserelin Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 TerSera Goserelin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 TerSera Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Goserelin Drug Industry Chain Analysis
12.2 Goserelin Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Goserelin Drug Production Mode & Process
12.4 Goserelin Drug Sales and Marketing
12.4.1 Goserelin Drug Sales Channels
12.4.2 Goserelin Drug Distributors
12.5 Goserelin Drug Customers
13 Market Dynamics
13.1 Goserelin Drug Industry Trends
13.2 Goserelin Drug Market Drivers
13.3 Goserelin Drug Market Challenges
13.4 Goserelin Drug Market Restraints
14 Key Findings in The Global Goserelin Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Goserelin Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of 3.6 mg
Table 3. Major Manufacturers of 10.8 mg
Table 4. Global Goserelin Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Goserelin Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Goserelin Drug Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Goserelin Drug Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Goserelin Drug Revenue Market Share by Region (2019-2024)
Table 9. Global Goserelin Drug Revenue Market Share by Region (2025-2030)
Table 10. Global Goserelin Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Goserelin Drug Sales by Region (2019-2024) & (K Units)
Table 12. Global Goserelin Drug Sales by Region (2025-2030) & (K Units)
Table 13. Global Goserelin Drug Sales Market Share by Region (2019-2024)
Table 14. Global Goserelin Drug Sales Market Share by Region (2025-2030)
Table 15. Global Goserelin Drug Sales by Manufacturers (2019-2024) & (K Units)
Table 16. Global Goserelin Drug Sales Share by Manufacturers (2019-2024)
Table 17. Global Goserelin Drug Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Goserelin Drug Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Goserelin Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Goserelin Drug Price by Manufacturers 2019-2024 (US$/Unit)
Table 21. Global Goserelin Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Goserelin Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Goserelin Drug as of 2023)
Table 23. Global Key Manufacturers of Goserelin Drug, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Goserelin Drug, Product Offered and Application
Table 25. Global Key Manufacturers of Goserelin Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Goserelin Drug Sales by Type (2019-2024) & (K Units)
Table 28. Global Goserelin Drug Sales by Type (2025-2030) & (K Units)
Table 29. Global Goserelin Drug Sales Share by Type (2019-2024)
Table 30. Global Goserelin Drug Sales Share by Type (2025-2030)
Table 31. Global Goserelin Drug Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Goserelin Drug Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Goserelin Drug Revenue Share by Type (2019-2024)
Table 34. Global Goserelin Drug Revenue Share by Type (2025-2030)
Table 35. Goserelin Drug Price by Type (2019-2024) & (US$/Unit)
Table 36. Global Goserelin Drug Price Forecast by Type (2025-2030) & (US$/Unit)
Table 37. Global Goserelin Drug Sales by Application (2019-2024) & (K Units)
Table 38. Global Goserelin Drug Sales by Application (2025-2030) & (K Units)
Table 39. Global Goserelin Drug Sales Share by Application (2019-2024)
Table 40. Global Goserelin Drug Sales Share by Application (2025-2030)
Table 41. Global Goserelin Drug Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Goserelin Drug Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Goserelin Drug Revenue Share by Application (2019-2024)
Table 44. Global Goserelin Drug Revenue Share by Application (2025-2030)
Table 45. Goserelin Drug Price by Application (2019-2024) & (US$/Unit)
Table 46. Global Goserelin Drug Price Forecast by Application (2025-2030) & (US$/Unit)
Table 47. US & Canada Goserelin Drug Sales by Type (2019-2024) & (K Units)
Table 48. US & Canada Goserelin Drug Sales by Type (2025-2030) & (K Units)
Table 49. US & Canada Goserelin Drug Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Goserelin Drug Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Goserelin Drug Sales by Application (2019-2024) & (K Units)
Table 52. US & Canada Goserelin Drug Sales by Application (2025-2030) & (K Units)
Table 53. US & Canada Goserelin Drug Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Goserelin Drug Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Goserelin Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Goserelin Drug Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Goserelin Drug Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Goserelin Drug Sales by Country (2019-2024) & (K Units)
Table 59. US & Canada Goserelin Drug Sales by Country (2025-2030) & (K Units)
Table 60. Europe Goserelin Drug Sales by Type (2019-2024) & (K Units)
Table 61. Europe Goserelin Drug Sales by Type (2025-2030) & (K Units)
Table 62. Europe Goserelin Drug Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Goserelin Drug Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Goserelin Drug Sales by Application (2019-2024) & (K Units)
Table 65. Europe Goserelin Drug Sales by Application (2025-2030) & (K Units)
Table 66. Europe Goserelin Drug Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Goserelin Drug Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Goserelin Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Goserelin Drug Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Goserelin Drug Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Goserelin Drug Sales by Country (2019-2024) & (K Units)
Table 72. Europe Goserelin Drug Sales by Country (2025-2030) & (K Units)
Table 73. China Goserelin Drug Sales by Type (2019-2024) & (K Units)
Table 74. China Goserelin Drug Sales by Type (2025-2030) & (K Units)
Table 75. China Goserelin Drug Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Goserelin Drug Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Goserelin Drug Sales by Application (2019-2024) & (K Units)
Table 78. China Goserelin Drug Sales by Application (2025-2030) & (K Units)
Table 79. China Goserelin Drug Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Goserelin Drug Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Goserelin Drug Sales by Type (2019-2024) & (K Units)
Table 82. Asia Goserelin Drug Sales by Type (2025-2030) & (K Units)
Table 83. Asia Goserelin Drug Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Goserelin Drug Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Goserelin Drug Sales by Application (2019-2024) & (K Units)
Table 86. Asia Goserelin Drug Sales by Application (2025-2030) & (K Units)
Table 87. Asia Goserelin Drug Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Goserelin Drug Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Goserelin Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Goserelin Drug Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Goserelin Drug Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Goserelin Drug Sales by Region (2019-2024) & (K Units)
Table 93. Asia Goserelin Drug Sales by Region (2025-2030) & (K Units)
Table 94. Middle East, Africa and Latin America Goserelin Drug Sales by Type (2019-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Goserelin Drug Sales by Type (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Goserelin Drug Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Goserelin Drug Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Goserelin Drug Sales by Application (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Goserelin Drug Sales by Application (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Goserelin Drug Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Goserelin Drug Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Goserelin Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Goserelin Drug Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Goserelin Drug Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Goserelin Drug Sales by Country (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Goserelin Drug Sales by Country (2025-2030) & (K Units)
Table 107. AstraZeneca Company Information
Table 108. AstraZeneca Description and Major Businesses
Table 109. AstraZeneca Goserelin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. AstraZeneca Goserelin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. AstraZeneca Recent Developments
Table 112. TerSera Company Information
Table 113. TerSera Description and Major Businesses
Table 114. TerSera Goserelin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. TerSera Goserelin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. TerSera Recent Developments
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Goserelin Drug Distributors List
Table 120. Goserelin Drug Customers List
Table 121. Goserelin Drug Market Trends
Table 122. Goserelin Drug Market Drivers
Table 123. Goserelin Drug Market Challenges
Table 124. Goserelin Drug Market Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Goserelin Drug Product Picture
Figure 2. Global Goserelin Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Goserelin Drug Market Share by Type in 2023 & 2030
Figure 4. 3.6 mg Product Picture
Figure 5. 10.8 mg Product Picture
Figure 6. Global Goserelin Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Goserelin Drug Market Share by Application in 2023 & 2030
Figure 8. Prostate Cancer
Figure 9. Breast Cancer
Figure 10. Endometriosis
Figure 11. Other
Figure 12. Goserelin Drug Report Years Considered
Figure 13. Global Goserelin Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Goserelin Drug Revenue 2019-2030 (US$ Million)
Figure 15. Global Goserelin Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Goserelin Drug Revenue Market Share by Region (2019-2030)
Figure 17. Global Goserelin Drug Sales 2019-2030 ((K Units)
Figure 18. Global Goserelin Drug Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Goserelin Drug Sales YoY (2019-2030) & (K Units)
Figure 20. US & Canada Goserelin Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Goserelin Drug Sales YoY (2019-2030) & (K Units)
Figure 22. Europe Goserelin Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Goserelin Drug Sales YoY (2019-2030) & (K Units)
Figure 24. China Goserelin Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) Goserelin Drug Sales YoY (2019-2030) & (K Units)
Figure 26. Asia (excluding China) Goserelin Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Goserelin Drug Sales YoY (2019-2030) & (K Units)
Figure 28. Middle East, Africa and Latin America Goserelin Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Goserelin Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 30. The Top 5 and 10 Largest Manufacturers of Goserelin Drug in the World: Market Share by Goserelin Drug Revenue in 2023
Figure 31. Global Goserelin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Goserelin Drug Sales Market Share by Type (2019-2030)
Figure 33. Global Goserelin Drug Revenue Market Share by Type (2019-2030)
Figure 34. Global Goserelin Drug Sales Market Share by Application (2019-2030)
Figure 35. Global Goserelin Drug Revenue Market Share by Application (2019-2030)
Figure 36. US & Canada Goserelin Drug Sales Market Share by Type (2019-2030)
Figure 37. US & Canada Goserelin Drug Revenue Market Share by Type (2019-2030)
Figure 38. US & Canada Goserelin Drug Sales Market Share by Application (2019-2030)
Figure 39. US & Canada Goserelin Drug Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Goserelin Drug Revenue Share by Country (2019-2030)
Figure 41. US & Canada Goserelin Drug Sales Share by Country (2019-2030)
Figure 42. U.S. Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 43. Canada Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 44. Europe Goserelin Drug Sales Market Share by Type (2019-2030)
Figure 45. Europe Goserelin Drug Revenue Market Share by Type (2019-2030)
Figure 46. Europe Goserelin Drug Sales Market Share by Application (2019-2030)
Figure 47. Europe Goserelin Drug Revenue Market Share by Application (2019-2030)
Figure 48. Europe Goserelin Drug Revenue Share by Country (2019-2030)
Figure 49. Europe Goserelin Drug Sales Share by Country (2019-2030)
Figure 50. Germany Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 51. France Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 52. U.K. Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 53. Italy Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 54. Russia Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 55. China Goserelin Drug Sales Market Share by Type (2019-2030)
Figure 56. China Goserelin Drug Revenue Market Share by Type (2019-2030)
Figure 57. China Goserelin Drug Sales Market Share by Application (2019-2030)
Figure 58. China Goserelin Drug Revenue Market Share by Application (2019-2030)
Figure 59. Asia Goserelin Drug Sales Market Share by Type (2019-2030)
Figure 60. Asia Goserelin Drug Revenue Market Share by Type (2019-2030)
Figure 61. Asia Goserelin Drug Sales Market Share by Application (2019-2030)
Figure 62. Asia Goserelin Drug Revenue Market Share by Application (2019-2030)
Figure 63. Asia Goserelin Drug Revenue Share by Region (2019-2030)
Figure 64. Asia Goserelin Drug Sales Share by Region (2019-2030)
Figure 65. Japan Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 66. South Korea Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 67. China Taiwan Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 68. Southeast Asia Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 69. India Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Goserelin Drug Sales Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Goserelin Drug Revenue Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Goserelin Drug Sales Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Goserelin Drug Revenue Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Goserelin Drug Revenue Share by Country (2019-2030)
Figure 75. Middle East, Africa and Latin America Goserelin Drug Sales Share by Country (2019-2030)
Figure 76. Brazil Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 77. Mexico Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 78. Turkey Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 79. Israel Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 80. GCC Countries Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 81. Goserelin Drug Value Chain
Figure 82. Goserelin Drug Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
Table 1. Global Goserelin Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of 3.6 mg
Table 3. Major Manufacturers of 10.8 mg
Table 4. Global Goserelin Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Goserelin Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Goserelin Drug Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Goserelin Drug Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Goserelin Drug Revenue Market Share by Region (2019-2024)
Table 9. Global Goserelin Drug Revenue Market Share by Region (2025-2030)
Table 10. Global Goserelin Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Goserelin Drug Sales by Region (2019-2024) & (K Units)
Table 12. Global Goserelin Drug Sales by Region (2025-2030) & (K Units)
Table 13. Global Goserelin Drug Sales Market Share by Region (2019-2024)
Table 14. Global Goserelin Drug Sales Market Share by Region (2025-2030)
Table 15. Global Goserelin Drug Sales by Manufacturers (2019-2024) & (K Units)
Table 16. Global Goserelin Drug Sales Share by Manufacturers (2019-2024)
Table 17. Global Goserelin Drug Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Goserelin Drug Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Goserelin Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Goserelin Drug Price by Manufacturers 2019-2024 (US$/Unit)
Table 21. Global Goserelin Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Goserelin Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Goserelin Drug as of 2023)
Table 23. Global Key Manufacturers of Goserelin Drug, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Goserelin Drug, Product Offered and Application
Table 25. Global Key Manufacturers of Goserelin Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Goserelin Drug Sales by Type (2019-2024) & (K Units)
Table 28. Global Goserelin Drug Sales by Type (2025-2030) & (K Units)
Table 29. Global Goserelin Drug Sales Share by Type (2019-2024)
Table 30. Global Goserelin Drug Sales Share by Type (2025-2030)
Table 31. Global Goserelin Drug Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Goserelin Drug Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Goserelin Drug Revenue Share by Type (2019-2024)
Table 34. Global Goserelin Drug Revenue Share by Type (2025-2030)
Table 35. Goserelin Drug Price by Type (2019-2024) & (US$/Unit)
Table 36. Global Goserelin Drug Price Forecast by Type (2025-2030) & (US$/Unit)
Table 37. Global Goserelin Drug Sales by Application (2019-2024) & (K Units)
Table 38. Global Goserelin Drug Sales by Application (2025-2030) & (K Units)
Table 39. Global Goserelin Drug Sales Share by Application (2019-2024)
Table 40. Global Goserelin Drug Sales Share by Application (2025-2030)
Table 41. Global Goserelin Drug Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Goserelin Drug Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Goserelin Drug Revenue Share by Application (2019-2024)
Table 44. Global Goserelin Drug Revenue Share by Application (2025-2030)
Table 45. Goserelin Drug Price by Application (2019-2024) & (US$/Unit)
Table 46. Global Goserelin Drug Price Forecast by Application (2025-2030) & (US$/Unit)
Table 47. US & Canada Goserelin Drug Sales by Type (2019-2024) & (K Units)
Table 48. US & Canada Goserelin Drug Sales by Type (2025-2030) & (K Units)
Table 49. US & Canada Goserelin Drug Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Goserelin Drug Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Goserelin Drug Sales by Application (2019-2024) & (K Units)
Table 52. US & Canada Goserelin Drug Sales by Application (2025-2030) & (K Units)
Table 53. US & Canada Goserelin Drug Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Goserelin Drug Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Goserelin Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Goserelin Drug Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Goserelin Drug Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Goserelin Drug Sales by Country (2019-2024) & (K Units)
Table 59. US & Canada Goserelin Drug Sales by Country (2025-2030) & (K Units)
Table 60. Europe Goserelin Drug Sales by Type (2019-2024) & (K Units)
Table 61. Europe Goserelin Drug Sales by Type (2025-2030) & (K Units)
Table 62. Europe Goserelin Drug Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Goserelin Drug Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Goserelin Drug Sales by Application (2019-2024) & (K Units)
Table 65. Europe Goserelin Drug Sales by Application (2025-2030) & (K Units)
Table 66. Europe Goserelin Drug Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Goserelin Drug Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Goserelin Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Goserelin Drug Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Goserelin Drug Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Goserelin Drug Sales by Country (2019-2024) & (K Units)
Table 72. Europe Goserelin Drug Sales by Country (2025-2030) & (K Units)
Table 73. China Goserelin Drug Sales by Type (2019-2024) & (K Units)
Table 74. China Goserelin Drug Sales by Type (2025-2030) & (K Units)
Table 75. China Goserelin Drug Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Goserelin Drug Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Goserelin Drug Sales by Application (2019-2024) & (K Units)
Table 78. China Goserelin Drug Sales by Application (2025-2030) & (K Units)
Table 79. China Goserelin Drug Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Goserelin Drug Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Goserelin Drug Sales by Type (2019-2024) & (K Units)
Table 82. Asia Goserelin Drug Sales by Type (2025-2030) & (K Units)
Table 83. Asia Goserelin Drug Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Goserelin Drug Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Goserelin Drug Sales by Application (2019-2024) & (K Units)
Table 86. Asia Goserelin Drug Sales by Application (2025-2030) & (K Units)
Table 87. Asia Goserelin Drug Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Goserelin Drug Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Goserelin Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Goserelin Drug Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Goserelin Drug Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Goserelin Drug Sales by Region (2019-2024) & (K Units)
Table 93. Asia Goserelin Drug Sales by Region (2025-2030) & (K Units)
Table 94. Middle East, Africa and Latin America Goserelin Drug Sales by Type (2019-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Goserelin Drug Sales by Type (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Goserelin Drug Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Goserelin Drug Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Goserelin Drug Sales by Application (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Goserelin Drug Sales by Application (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Goserelin Drug Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Goserelin Drug Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Goserelin Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Goserelin Drug Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Goserelin Drug Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Goserelin Drug Sales by Country (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Goserelin Drug Sales by Country (2025-2030) & (K Units)
Table 107. AstraZeneca Company Information
Table 108. AstraZeneca Description and Major Businesses
Table 109. AstraZeneca Goserelin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. AstraZeneca Goserelin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. AstraZeneca Recent Developments
Table 112. TerSera Company Information
Table 113. TerSera Description and Major Businesses
Table 114. TerSera Goserelin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. TerSera Goserelin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. TerSera Recent Developments
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Goserelin Drug Distributors List
Table 120. Goserelin Drug Customers List
Table 121. Goserelin Drug Market Trends
Table 122. Goserelin Drug Market Drivers
Table 123. Goserelin Drug Market Challenges
Table 124. Goserelin Drug Market Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Goserelin Drug Product Picture
Figure 2. Global Goserelin Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Goserelin Drug Market Share by Type in 2023 & 2030
Figure 4. 3.6 mg Product Picture
Figure 5. 10.8 mg Product Picture
Figure 6. Global Goserelin Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Goserelin Drug Market Share by Application in 2023 & 2030
Figure 8. Prostate Cancer
Figure 9. Breast Cancer
Figure 10. Endometriosis
Figure 11. Other
Figure 12. Goserelin Drug Report Years Considered
Figure 13. Global Goserelin Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Goserelin Drug Revenue 2019-2030 (US$ Million)
Figure 15. Global Goserelin Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Goserelin Drug Revenue Market Share by Region (2019-2030)
Figure 17. Global Goserelin Drug Sales 2019-2030 ((K Units)
Figure 18. Global Goserelin Drug Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Goserelin Drug Sales YoY (2019-2030) & (K Units)
Figure 20. US & Canada Goserelin Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Goserelin Drug Sales YoY (2019-2030) & (K Units)
Figure 22. Europe Goserelin Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Goserelin Drug Sales YoY (2019-2030) & (K Units)
Figure 24. China Goserelin Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) Goserelin Drug Sales YoY (2019-2030) & (K Units)
Figure 26. Asia (excluding China) Goserelin Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Goserelin Drug Sales YoY (2019-2030) & (K Units)
Figure 28. Middle East, Africa and Latin America Goserelin Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Goserelin Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 30. The Top 5 and 10 Largest Manufacturers of Goserelin Drug in the World: Market Share by Goserelin Drug Revenue in 2023
Figure 31. Global Goserelin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Goserelin Drug Sales Market Share by Type (2019-2030)
Figure 33. Global Goserelin Drug Revenue Market Share by Type (2019-2030)
Figure 34. Global Goserelin Drug Sales Market Share by Application (2019-2030)
Figure 35. Global Goserelin Drug Revenue Market Share by Application (2019-2030)
Figure 36. US & Canada Goserelin Drug Sales Market Share by Type (2019-2030)
Figure 37. US & Canada Goserelin Drug Revenue Market Share by Type (2019-2030)
Figure 38. US & Canada Goserelin Drug Sales Market Share by Application (2019-2030)
Figure 39. US & Canada Goserelin Drug Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Goserelin Drug Revenue Share by Country (2019-2030)
Figure 41. US & Canada Goserelin Drug Sales Share by Country (2019-2030)
Figure 42. U.S. Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 43. Canada Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 44. Europe Goserelin Drug Sales Market Share by Type (2019-2030)
Figure 45. Europe Goserelin Drug Revenue Market Share by Type (2019-2030)
Figure 46. Europe Goserelin Drug Sales Market Share by Application (2019-2030)
Figure 47. Europe Goserelin Drug Revenue Market Share by Application (2019-2030)
Figure 48. Europe Goserelin Drug Revenue Share by Country (2019-2030)
Figure 49. Europe Goserelin Drug Sales Share by Country (2019-2030)
Figure 50. Germany Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 51. France Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 52. U.K. Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 53. Italy Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 54. Russia Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 55. China Goserelin Drug Sales Market Share by Type (2019-2030)
Figure 56. China Goserelin Drug Revenue Market Share by Type (2019-2030)
Figure 57. China Goserelin Drug Sales Market Share by Application (2019-2030)
Figure 58. China Goserelin Drug Revenue Market Share by Application (2019-2030)
Figure 59. Asia Goserelin Drug Sales Market Share by Type (2019-2030)
Figure 60. Asia Goserelin Drug Revenue Market Share by Type (2019-2030)
Figure 61. Asia Goserelin Drug Sales Market Share by Application (2019-2030)
Figure 62. Asia Goserelin Drug Revenue Market Share by Application (2019-2030)
Figure 63. Asia Goserelin Drug Revenue Share by Region (2019-2030)
Figure 64. Asia Goserelin Drug Sales Share by Region (2019-2030)
Figure 65. Japan Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 66. South Korea Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 67. China Taiwan Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 68. Southeast Asia Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 69. India Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Goserelin Drug Sales Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Goserelin Drug Revenue Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Goserelin Drug Sales Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Goserelin Drug Revenue Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Goserelin Drug Revenue Share by Country (2019-2030)
Figure 75. Middle East, Africa and Latin America Goserelin Drug Sales Share by Country (2019-2030)
Figure 76. Brazil Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 77. Mexico Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 78. Turkey Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 79. Israel Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 80. GCC Countries Goserelin Drug Revenue (2019-2030) & (US$ Million)
Figure 81. Goserelin Drug Value Chain
Figure 82. Goserelin Drug Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Mining Truck Mounted Drill Rigs Market Research Report 2025
Apr 07, 25
Global Bulk Material Drag Chain Conveyor Market Research Report 2025
Apr 07, 25
Global Boom-type Mining Roadheader Market Research Report 2025
Apr 07, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232